Apimeds Pharmaceuticals US (APUS) has filed for 3,333,334 share IPO at $3-$4 per share.
This post appeared first on investing.com
You may also like
US SEC issues summons for India’s Adani, nephew on bribery allegations
(Corrects paragraph 1 to remove extraneous ‘the’) (Reuters) -The U.S. Securities and Exchange Commission has ...
UBS looks at key developments that will shape the next stage of this decade
Investing.com — As 2025 approaches, UBS analysts identified critical factors that will shape the global ...